Why Investigator Meetings Are Considered Valuable?
Investigator meetings play a very important role in clinical research. It has been widely accepted that they are placed at the core of clinical studies because of their agenda and because of their purpose. Originally, such meetings have the primary goal to ensure maximum clarification regarding protocols, quality of data, regulations, correct documentation practices and so on. In other words, investigator face-to-face conferences of this type help contract research organisations (CROs) and/or sponsors of clinical trials understand legislations, formal clinical study guidelines and recommendations. Just think about the voluminous information which the personnel involved is expected to understand about protocols — from inclusion/exclusion criteria, through adverse event reporting, to recruitment tactics. Isn’t that enough to cause a headache or confusion? Still, investigator meetings effectively communicate all of the requirements to the study personnel in a clean and easy to understand manner. There are also sessions on Good Clinical Practice (GCP) which have the primary goal to clarify all ethical and quality standards. Receiving such comprehensive information allows them to collect consistent, adequate, reliable and objective data. But what is even more, learning about the requirements improves the performance of participating study sites.
Moreover, usually people with varying professional backgrounds attend these events — from industry leaders to newcomers. So investigator meetings not only give sponsors and CROs an opportunity to meet colleagues from different locations but they also allow them to share expertise, exchange ideas and talk about their practices. On the whole, it’s a good way of learning both for investigators and others with similar positions.
In addition to this, the interactivity of these dialogues help sponsors and the rest of the clinical trial personnel build better relations between themselves or establish better communication. Which becomes a chance for networking on its own. Thus, attendees can really make new connections and retain contacts with new sponsors.
To sum up, it is not a secret that contract research organisations and sponsors have many responsibilities. But one of the most cardinal ones is to make sure that every process is compliant with regulations, be that local or international too. Moreover, having correct documentation is also very crucial to clinical trials, so everyone who is involved should be familiar with key guidance, legislations and requirements. That’s why investigator meetings take place. They cast light on these subject matters and refer to the most appropriate approaches that can be implemented.